Skin Cancer

Two-time cancer survivor shares her thoughts about that small, quiet voice.

Recent years brought many advances in the field of immunotherapy in melanoma, but more still needs to be done.

When used in combination, Cotellic and Zelboraf showed a significant reduction in death rates for some patients with melanoma.

This is my wish list for all cancer survivors across all types of cancer who struggle with cancer's emotional isolation.

Claire Friedman, Memorial Sloan Kettering Cancer Center, discusses some of the factors that doctors and elderly patients with melanoma should discuss before deciding on a treatment plan with immunotherapy. Immunotherapy is not one-size-fits all, and patients should be informed of the pros and cons of each option.

A recent study revealed that people of color tend to have poorer prognoses than white people when diagnosed with melanoma.

Breast cancer and melanoma survivor shares time management tips to fellow survivors.

Time is limited and the time for experiences with loved ones is today, writes breast cancer survivor Barbara Tako.

Musings on mortality

Before cancer, two-time survivor Barbara Tako writes that she was in more of a hurry.

Breast cancer survivor reflects on the mental and emotional effects of cancer treatments.

In a phase 3 trial, binimetinib is showing promise for some melanoma patients who had disease progression on immunotherapy.

Support groups aren't for everyone, but finding even one other patient or survivor you can relate to can make all the difference in not feeling completely isolated.

Breast cancer and melanoma survivor tries to help her mom with breast cancer treatment choices.

Breast cancer survivor Barbara Tako recalls a Fourth of July holiday during her chemotherapy treatments.

In recent years, concern has grown over the ultraviolet (UV) lights used to dry the gel nail polish. They give off UVA rays, which cause aging and skin cancer.

Early detection of new or recurrent melanoma can be aided by checking skin with a partner who has been trained to identify concerning moles on the body.

Deciding on treatment for melanoma does not have to be a guessing game, says Keith T. Flaherty.

Why don't I feel myself? Why do so many of us (survivors) still say that months and years out, asks Barbara Tako

Breast cancer and melanoma survivor has many birthday wishes when she blows the candles out on her birthday cake.

A small, early trial demonstrated that a combination of Imlygic and Keytruda can have clinical benefit for patients with advanced melanoma.

Binimetinib, an experimental targeted drug, reduced the risk of disease progression or death in patients with NRAS-mutant metastatic melanoma in a recent phase 3 study.